RESUMEN
In the present work, we show that T-cell lymphoblastic lymphoma cells exhibit a reduction of FADD availability in the cytoplasm, which may contribute to impaired apoptosis. In addition, we observe a reduction of FADD phosphorylation that inversely correlates with the proliferation capacity and tumor aggressiveness. The resultant balance between FADD-dependent apoptotic and non-apoptotic abilities may define the outcome of the tumor. Thus, we propose that FADD expression and phosphorylation can be reliable biomarkers with prognostic value for T-LBL stratification.
Asunto(s)
Biomarcadores de Tumor/metabolismo , Proteína de Dominio de Muerte Asociada a Fas/metabolismo , Regulación Neoplásica de la Expresión Génica , Leucemia-Linfoma Linfoblástico de Células T Precursoras/genética , Leucemia-Linfoma Linfoblástico de Células T Precursoras/patología , Animales , Apoptosis , Biomarcadores de Tumor/genética , Caseína Quinasa Ialfa/metabolismo , Proliferación Celular , Citoplasma/metabolismo , ADN Complementario/genética , ADN Complementario/aislamiento & purificación , Regulación hacia Abajo , Fosfatasas de Especificidad Dual/metabolismo , Proteína de Dominio de Muerte Asociada a Fas/genética , Femenino , Perfilación de la Expresión Génica , Humanos , Inmunohistoquímica , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Células Jurkat , Estimación de Kaplan-Meier , Leucemia Experimental/genética , Leucemia Experimental/mortalidad , Leucemia Experimental/patología , Ratones , Ratones Endogámicos C57BL , Fosfatasas de la Proteína Quinasa Activada por Mitógenos/metabolismo , Fosforilación , Leucemia-Linfoma Linfoblástico de Células T Precursoras/mortalidad , Pronóstico , Proteínas Serina-Treonina Quinasas/metabolismo , Medición de Riesgo/métodos , Análisis de Secuencia de ADN , Serina/metabolismo , Timocitos/metabolismo , Timocitos/patología , Regulación hacia ArribaRESUMEN
The first intercellular differences during mammalian embryogenesis arise in the blastocyst, producing the inner cell mass and the trophectoderm. The trophectoderm is the first extraembryonic tissue and does not contribute to the embryo proper, its differentiation instead forming tissues that sustain embryonic development. Crucial roles in extraembryonic differentiation have been identified for certain transcription factors, but a comprehensive picture of the regulation of this early specification is still lacking. Here, we investigated whether the regulatory mechanisms involved in Cdx2 expression in the blastocyst are also utilized in the postimplantation embryo. We analyzed an enhancer that is regulated through Hippo and Notch in the blastocyst trophectoderm, unexpectedly finding that it is inactive in the extraembryonic structures at postimplantation stages. Further analysis identified other Cdx2 regulatory elements including a stem-cell specific regulatory sequence and an element that drives reporter expression in the trophectoderm, a subset of cells in the extraembryonic region of the postimplantation embryo and in trophoblast stem cells. The cross-comparison in this study of cis-regulatory elements employed in the blastocyst, stem cell populations and the postimplantation embryo provides new insights into early mammalian development and suggests a two-step mechanism in Cdx2 regulation.
Asunto(s)
Blastocisto/metabolismo , Factor de Transcripción CDX2/genética , Elementos de Facilitación Genéticos , Células Madre Fetales/metabolismo , Trofoblastos/metabolismo , Animales , Blastocisto/citología , Factor de Transcripción CDX2/metabolismo , Diferenciación Celular , Células Cultivadas , Implantación del Embrión , Desarrollo Embrionario , Femenino , Células Madre Fetales/citología , Regulación del Desarrollo de la Expresión Génica , Ratones , Factores de Transcripción/metabolismo , Trofoblastos/citologíaRESUMEN
Reprogramming of adult cells to generate induced pluripotent stem cells (iPS cells) has opened new therapeutic opportunities; however, little is known about the possibility of in vivo reprogramming within tissues. Here we show that transitory induction of the four factors Oct4, Sox2, Klf4 and c-Myc in mice results in teratomas emerging from multiple organs, implying that full reprogramming can occur in vivo. Analyses of the stomach, intestine, pancreas and kidney reveal groups of dedifferentiated cells that express the pluripotency marker NANOG, indicative of in situ reprogramming. By bone marrow transplantation, we demonstrate that haematopoietic cells can also be reprogrammed in vivo. Notably, reprogrammable mice present circulating iPS cells in the blood and, at the transcriptome level, these in vivo generated iPS cells are closer to embryonic stem cells (ES cells) than standard in vitro generated iPS cells. Moreover, in vivo iPS cells efficiently contribute to the trophectoderm lineage, suggesting that they achieve a more plastic or primitive state than ES cells. Finally, intraperitoneal injection of in vivo iPS cells generates embryo-like structures that express embryonic and extraembryonic markers. We conclude that reprogramming in vivo is feasible and confers totipotency features absent in standard iPS or ES cells. These discoveries could be relevant for future applications of reprogramming in regenerative medicine.